CompaniesHarlan Laboratories

Harlan Laboratories

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

3

As Collaborator

2

Total Enrollment

1,059

By Phase

NA: 3

By Status

COMPLETED: 3UNKNOWN: 2
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
NCT02873052
NCT04804969
Hover over trial bars to see details

Recent Trials

NCT05364541Lead Sponsor
MyoVista wavECG Clinical Evaluation: >=60 y/o Enrichment Population
NAUnknown
50 participants
Started: Jun 1, 2022 · Completed: Nov 30, 2023
NCT04804969Lead Sponsor
MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram
N/AUnknown
575 participants
Started: May 10, 2021 · Completed: Nov 30, 2023
NCT05468879Lead Sponsor
Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects
NACompleted
34 participants
Started: Sep 21, 2020 · Completed: Jan 6, 2021
NCT02560168Collaborator
Analysis of Surface EKG Signals to Identify Myocardial Dysfunction in Patients at Risk for Coronary Artery Disease
NACompleted
200 participants
Started: Oct 31, 2015 · Completed: Jun 30, 2016
NCT02873052Collaborator
MyoVista Measurements in Patients With Atherosclerosis and CAD
N/ACompleted
200 participants
Started: Sep 1, 2015 · Completed: Feb 22, 2020